Correlation Between DiaMedica Therapeutics and Krystal Biotech

Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Krystal Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Krystal Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DiaMedica Therapeutics and Krystal Biotech, you can compare the effects of market volatilities on DiaMedica Therapeutics and Krystal Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Krystal Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Krystal Biotech.

Diversification Opportunities for DiaMedica Therapeutics and Krystal Biotech

0.15

Correlation Coefficient

DiaMedica Therapeutics  Krystal Biotech

Average diversification

The 3 months correlation between DiaMedica and Krystal is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Krystal Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krystal Biotech and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Krystal Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krystal Biotech has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Krystal Biotech go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Krystal Biotech

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.09 times more return on investment than Krystal Biotech. However, DiaMedica Therapeutics is 1.09 times more volatile than Krystal Biotech. It trades about 0.15 of its potential returns per unit of risk. Krystal Biotech is currently generating about 0.13 per unit of risk. If you would invest  551.00  in DiaMedica Therapeutics on December 2, 2024 and sell it today you would earn a total of  102.00  from holding DiaMedica Therapeutics or generate 18.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

DiaMedica Therapeutics  vs.  Krystal Biotech

DiaMedica Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Krystal Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Krystal Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with DiaMedica Therapeutics and Krystal Biotech

The main advantage of trading using opposite DiaMedica Therapeutics and Krystal Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Krystal Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krystal Biotech will offset losses from the drop in Krystal Biotech's long position.

The idea behind DiaMedica Therapeutics and Krystal Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.